Clinical trial
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access…
NCT00073515 · ARCA Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00073515 |
|---|---|
| Title | Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices |
| Official title | A Phase 2, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Catheters, Indwelling |
| Intervention type | Drug |
| Interventions | Alfimeprase |
| Enrollment | 115 |
| First posted | Nov 25, 2003 |
| Last update posted | Feb 3, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: